45.What is the type of authorisation granted to Covishield and Covaxin vaccines, as of January 2022? [A] Emergency Use Authorisation [B] Conditional Market Authorisation [C] Essential Market Authorisation [D] Full Market Authorisation
The drug regulator has granted Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin Covid-19 vaccines “conditional market authorisation”. Since January last year, the two vaccines have been available under “Emergency Use Authorisation” (EUA). They have to submit the safety and efficacy data every six months, under the new authorisation against 15 days earlier. This is different from the Full Market Authorisation.
